The Journal of Infectious Diseases · 1983 · 43 citations · 8 references
MedicineInfectious DiseasesPediatricsImmunizationNeonatologyPediatric Infectious DiseasesInfant Infectious DiseasesNeonatal ImmunityNeonatal ImmunologyNeonatal InfectionsNeonatal Infectious DiseasesPerinatal InfectionAntibiotic Therapy In NeonatesBacterial Infections In NewbornsGroup B Streptococcal PreventionIntrapartum Antibiotic ProphylaxisMaternal-intrapartum Antibiotic ProphylaxisNeonatal Bacterial InfectionPenicillin ProphylaxisVertical Transmission Control
Group B streptococci remain a serious cause of morbidity and mortality in neonates. GBS vaccine or immunoglobulin administered iv may enhance neonatal GBS immunity. Likewise, intrapartum antibiotic therapy of colonized mothers appears to reduce vertical transmission of group B streptococci and to prevent both maternal and neonatal GBS disease. However, the safety and effectiveness of routine penicillin prophylaxis less than or equal to 1 hr after birth remain in question. For example, penicillin prophylaxis appears to be of little value in infants with low birth weights (less than 2,000 g) who become symptomatic shortly after birth; however, it may reduce the incidence of disease in larger, full-term infants who acquire the group B streptococci at delivery or in the few hours immediately thereafter. The potential harm of administering penicillin to all neonates must also be considered, since routine antibiotic therapy may alter the incidence of both neonatal infections due to penicillin-resistant pathogens and possible later penicillin allergy. Theoretically, a single injection of penicillin at birth may suppress GBS disease in some neonates but not effectively treat it, allowing the disease to progress prior to diagnosis and therapy. The decision to use penicillin routinely in neonates to prevent GBS disease must therefore be made with caution. Presently, this decision must be made on a situational basis, with institutions having a high incidence of early-onset GBS disease electing to use penicillin only if the potential benefits outweigh the risks.
8
Ampicillin Prevents Intrapartum Transmission of Group B Streptococcus
Martha D. Yow · JAMA · 1979 · 224 citations
Prospective studies of group B streptococcal infections in infants
Mary Ann Pass, Barry M. Gray, Santosh Khare et al. · The Journal of Pediatrics · 1979 · 159 citations
SINGLE-DOSE PENICILLIN PROPHYLAXIS OF NEONATAL GROUP-B STREPTOCOCCAL DISEASE
JaneD Siegel, Norma Threlkeld, GeorgeH. McCracken et al. · The Lancet · 1982 · 88 citations